BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18757432)

  • 1. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
    Bernard-Pierrot I; Gruel N; Stransky N; Vincent-Salomon A; Reyal F; Raynal V; Vallot C; Pierron G; Radvanyi F; Delattre O
    Cancer Res; 2008 Sep; 68(17):7165-75. PubMed ID: 18757432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.
    Mahmood SF; Gruel N; Nicolle R; Chapeaublanc E; Delattre O; Radvanyi F; Bernard-Pierrot I
    Am J Pathol; 2013 Nov; 183(5):1634-1644. PubMed ID: 24051013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming properties of 8p11-12 amplified genes in human breast cancer.
    Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
    Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.
    Yang ZQ; Streicher KL; Ray ME; Abrams J; Ethier SP
    Cancer Res; 2006 Dec; 66(24):11632-43. PubMed ID: 17178857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
    Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
    Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive profiling of 8p11-12 amplification in breast cancer.
    Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
    Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.
    Streicher KL; Yang ZQ; Draghici S; Ethier SP
    Oncogene; 2007 Mar; 26(14):2104-14. PubMed ID: 17001308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
    Ray ME; Yang ZQ; Albertson D; Kleer CG; Washburn JG; Macoska JA; Ethier SP
    Cancer Res; 2004 Jan; 64(1):40-7. PubMed ID: 14729606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
    Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
    Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
    Yang ZQ; Albertson D; Ethier SP
    Cancer Genet Cytogenet; 2004 Nov; 155(1):57-62. PubMed ID: 15527903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.
    Mahmood SF; Gruel N; Chapeaublanc E; Lescure A; Jones T; Reyal F; Vincent-Salomon A; Raynal V; Pierron G; Perez F; Camonis J; Del Nery E; Delattre O; Radvanyi F; Bernard-Pierrot I
    Carcinogenesis; 2014 Mar; 35(3):670-82. PubMed ID: 24148822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
    Kwek SS; Roy R; Zhou H; Climent J; Martinez-Climent JA; Fridlyand J; Albertson DG
    Oncogene; 2009 Apr; 28(17):1892-903. PubMed ID: 19330026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.
    Luo J; Liu S; Leung S; Gru AA; Tao Y; Hoog J; Ho J; Davies SR; Allred DC; Salavaggione AL; Snider J; Mardis ER; Nielsen TO; Ellis MJ
    J Mol Diagn; 2017 Jan; 19(1):147-161. PubMed ID: 27993329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
    Tan DS; Lambros MB; Rayter S; Natrajan R; Vatcheva R; Gao Q; Marchiò C; Geyer FC; Savage K; Parry S; Fenwick K; Tamber N; Mackay A; Dexter T; Jameson C; McCluggage WG; Williams A; Graham A; Faratian D; El-Bahrawy M; Paige AJ; Gabra H; Gore ME; Zvelebil M; Lord CJ; Kaye SB; Ashworth A; Reis-Filho JS
    Clin Cancer Res; 2009 Apr; 15(7):2269-80. PubMed ID: 19293255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.
    Rodriguez V; Chen Y; Elkahloun A; Dutra A; Pak E; Chandrasekharappa S
    Genes Chromosomes Cancer; 2007 Jul; 46(7):694-707. PubMed ID: 17440925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
    Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
    Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.
    Yao J; Weremowicz S; Feng B; Gentleman RC; Marks JR; Gelman R; Brennan C; Polyak K
    Cancer Res; 2006 Apr; 66(8):4065-78. PubMed ID: 16618726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
    Dahl E; Kristiansen G; Gottlob K; Klaman I; Ebner E; Hinzmann B; Hermann K; Pilarsky C; Dürst M; Klinkhammer-Schalke M; Blaszyk H; Knuechel R; Hartmann A; Rosenthal A; Wild PJ
    Clin Cancer Res; 2006 Jul; 12(13):3950-60. PubMed ID: 16818692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
    Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
    Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
    Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
    Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.